Park Ha Biological Drops 10.9% as Fraud Lawsuits Pile Up — Is There Any Floor for a Penny Stock Built on Alleged Market Manipulation?
Shares of Park Ha Biological Technology (NASDAQ: BYAH) slid to $0.33, down 10.9%, as a wave of securities class-action lawsuits intensified pressure on a company already reeling from allegations that its stock price was artificially inflated. For holders of this penny stock, the legal onslaught raises a blunt question: what is the real value of a company whose trading history is now under federal court scrutiny?
• The Lawsuits Allege a Coordinated Fake-Hype Campaign, Not Just Bad Disclosure. The complaint alleges Park Ha was the subject of a market manipulation and fraudulent promotion scheme involving social-media misinformation and individuals impersonating financial professionals. At least three prominent law firms — Morris Kandinov, Robbins LLP, and Bronstein Gewirtz — have filed or joined suits in recent days. Plaintiffs claim the company's IPO was intentionally structured with an extremely low public float to enable the manipulation scheme , meaning the small number of shares available to trade made prices easier to push around. That is a far more serious accusation than a simple bookkeeping error — it implies the company's structure was designed to help the fraud work.
• The Stock Already Crashed 93% in a Single Day Last Year. According to the complaint, Park Ha experienced a dramatic collapse on July 8, 2025, after the alleged manipulation risks became apparent. The stock fell approximately 93% in a single day. Today's further 10.9% slide shows the damage is still compounding more than a year later, as lawsuit headlines remind the market of unresolved risk.
• Multiple Law Firms Are Competing for Plaintiffs, Signaling Serious Litigation Ahead. Investors who bought shares between December 27, 2024 and July 8, 2025 have until September 28, 2026 to seek appointment as lead plaintiff. The clustering of at least three firms racing for the same class underscores that attorneys see meaningful potential damages — a bad sign for the company's already thin balance sheet.
• At $0.33, the Stock Faces Existential Nasdaq Compliance Risk. Stocks trading below $1.00 for extended periods risk delisting from Nasdaq. With no visible catalyst to restore investor trust, any settlement payout or legal defense costs could overwhelm a micro-cap company whose recent trading range has hovered between $0.35 and $0.38. The complaint asserts defendants' positive statements about the company's business and prospects "were misleading and/or lacked a reasonable basis." Until Park Ha directly addresses these allegations, every uptick in its share price will be shadowed by the question of whether there is a legitimate business underneath.